Novavax, Inc. (NVAX)
8.64
-0.05
(-0.58%)
USD |
NASDAQ |
Apr 16, 16:00
8.73
+0.09
(+1.04%)
After-Hours: 04:38
Novavax Research and Development Expense (Quarterly) : 73.98M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.499B |
| Pfizer Inc. | 3.133B |
| Moderna, Inc. | 708.00M |
| Intellia Therapeutics, Inc. | 86.27M |
| Recursion Pharmaceuticals, Inc. | 83.34M |